Hepatitis B Virus E Antigen (HBeAg) Antikörper (Biotin)
-
- Target Alle Hepatitis B Virus E Antigen (HBeAg) Antikörper anzeigen
- Hepatitis B Virus E Antigen (HBeAg)
-
Reaktivität
- Hepatitis B Virus (HBV), Virus
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Biotin
-
Applikation
- ELISA, Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität
- Virus
- Kreuzreaktivität (Details)
- Hepatitis B Virus
- Aufreinigung
- Purified by Protein G.
- Immunogen
- HBeAg full length protein
- Klon
- 2E9
- Isotyp
- IgG
- Top Product
- Discover our top product HBeAg Primärantikörper
-
-
- Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C for 12 months.
- Haltbarkeit
- 12 months
-
- Target
- Hepatitis B Virus E Antigen (HBeAg)
- Abstract
- HBeAg Produkte
- Synonyme
- precore; HBe antigen; PreC; HBeAg; precore protein; external core antigen; HBeAg; p25 antikoerper, C antikoerper
- Substanzklasse
- Viral Protein
- Hintergrund
-
Synonyms: Hepatitis B, Core antigen, Core protein, HBe antigen, HBeAg, HBVgp4, Pre C,C, Precore protein, Precore/core, Precore/core ORF, Precore/core protei, HBEAG_HBVD3, External core antigen, HBeAg, p25.
Background: Hepatitis B e-antigen (HBeAg) is a viral protein associated with HBV infections. Unlike the surface antigen, the e-antigen is found in the blood only when there are viruses also present. When the virus goes into hiding,? the e-antigen will no longer be present in the blood. HBeAg is often used as a marker of ability to spread the virus to other people (infectivity). Measurement of e-antigen may also be used to monitor the effectiveness of HBV treatment, successful treatment will usually eliminate HBeAg from the blood and lead to development of against e-antigen (anti-HBe). There are some types (strains) of HBV that do not make e-antigen, these are especially common in the Middle East and Asia. In areas where these strains of HBV are common, testing for HBeAg is not very useful.
-